Last update 17 Jun 2025

SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Liposomal Drug
Synonyms
SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant, SARS-COV-2-Spike-Ferritin-Nanoparticle (SPFN_1B-06-PL) Vaccine With Army Liposomal Formulation QS21 (ALFQ)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesOther Diseases
Active Indication
COVID-19Severe Acute Respiratory Syndrome
Inactive Indication-
Originator Organization
U S Army Medical Research & Development CommandU S Army Medical Research & Development Command
Active Organization
U S Army Medical Research & Development CommandU S Army Medical Research & Development Command
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)
NCT04784767
/ CompletedPhase 1IIT
Randomized Double-blind Placebo-Controlled Study in Healthy Adults to Evaluate Safety/Tolerability/Immunogenicity of Ranging Doses SARS-COV-2SPFN_1B-06-PL With Army Liposomal Formulation QS21 (ALFQ) for Prevention of COVID-19
100 Clinical Results associated with SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)
Login to view more data
100 Translational Medicine associated with SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)
Login to view more data
100 Patents (Medical) associated with SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)
Login to view more data
100 Deals associated with SpFN_1B-06-PL adjuvanted with ALFQ(US Army Medical Research & Development Command)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 1
United States
U S Army Medical Research & Development CommandU S Army Medical Research & Development Command
05 Apr 2021
Severe Acute Respiratory SyndromePhase 1
United States
U S Army Medical Research & Development CommandU S Army Medical Research & Development Command
05 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free